Scholarlink

The most extensively used radiopharmaceutical in clinical practice is fluorine-18 fluorodeoxyglucose (18F-FDG). Extensive published evidence supports its use in oncology. Several non-FDG positron emission tomography imaging agents are also used in oncology. This chapter will explore the common questions related to science and practice, as well as the advantages and limitations of FDG and non-FDG tracers, and provide answers.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Positron Emission Tomography Tracers

  • 章节

  • 发表日期：

    2026年

查看全文
  • Senthil Raja,
  • Hian Liang Huang,
  • Cindy Leung,
  • Gopinath Gnanasegaran

摘要

The most extensively used radiopharmaceutical in clinical practice is fluorine-18 fluorodeoxyglucose (18F-FDG). Extensive published evidence supports its use in oncology. Several non-FDG positron emission tomography imaging agents are also used in oncology. This chapter will explore the common questions related to science and practice, as well as the advantages and limitations of FDG and non-FDG tracers, and provide answers.